(Reporting by Leroy Leo in Bengaluru; Editing by Shinjini Ganguli)
Moderna generates $18.4 billion in COVID vaccine sales in 2022
(Reuters) - Moderna Inc said on Monday it generated about $18.4 billion in COVID-19 vaccine sales in 2022.
![Reuters logo](/images/reuters.jpg)
Market Closed -
Other stock markets
|
Pre-market 08:12:16 | |||
125.1 USD | +3.01% |
|
123.6 | -1.27% |
10:20am | EU court criticizes Commission over handling of COVID vaccine contracts | RE |
07-15 | Moderna Insider Sold Shares Worth $1,756,177, According to a Recent SEC Filing | MT |
(Reuters) - Moderna Inc said on Monday it generated about $18.4 billion in COVID-19 vaccine sales in 2022.
(Reporting by Leroy Leo in Bengaluru; Editing by Shinjini Ganguli)
1st Jan change | Capi. | |
---|---|---|
+25.83% | 47.96B | |
+44.47% | 41.47B | |
+0.69% | 42.45B | |
+30.52% | 31.6B | |
+22.30% | 28.63B | |
-6.35% | 28.03B | |
+49.25% | 14.56B | |
+49.18% | 14.14B | |
+3.45% | 12.58B | |
-3.85% | 11.71B |